Application Note: WB: 0.25-0.5 μg/ml. ICC/IF: 5 μg/ml. IHC-P: 2-5 μg/ml. FACS: 1-3 μg/1x10⁶ cells. ELISA: 0.1-0.5 μg/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
Calculated MW: 65
Form: Liquid
Buffer (with preservative): 4 mg Trehalose, 0.9 mg NaCl, 0.2 mg Na₂HPO₄, no preservatives.
Concentration: 0.5 mg/ml (Please refer to the vial label for the specific concentration.)
Background: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described.[provided by RefSeq, Mar 2009]
Uniprot ID: SEPTIN9
Antigen Species: Human
Immunogen: E.coli-derived human MSF/SEPTIN9 recombinant protein (Position: R15-D282).
Purification: Purified by antigen-affinity chromatography
Conjugation: Unconjugated
Full Name: septin 9
Deutsch
English
